Explained: Russia’s Enteromix cancer vaccine, which shows promise in early trials
www.forbesindia.com
Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
  • Dudewitbow@lemmy.zipEnglish
    0·
    9 months ago

    Reading the article, kinda happy that different countries are working on different cancer fighting mrna options that currently are on different phases.

    • themurphy@lemmy.mlEnglish
      0·
      9 months ago

      That’s the thing about scientists. They dont give a fuck what country you are from.

      They are so used to working with people all over the world they might be the least hateful and least racist people ever.

      They just want to see the world burn cured.

      Their governments on the other hand…